Deferred Tax Assets, Operating Loss Carryforwards in USD of Roivant Sciences Ltd. from Q1 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Roivant Sciences Ltd. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q1 2021 to Q1 2025.
  • Roivant Sciences Ltd. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Mar 2025 was $469M, a 30.4% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Roivant Sciences Ltd. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $469M +$109M +30.4% 31 Mar 2025 10-K 29 May 2025
Q1 2024 $360M -$62.6M -14.8% 31 Mar 2024 10-K 29 May 2025
Q1 2023 $423M +$110M +35.1% 31 Mar 2023 10-K 30 May 2024
Q1 2022 $313M +$110M +54.1% 31 Mar 2022 10-K 28 Jun 2023
Q1 2021 $203M 31 Mar 2021 10-K 28 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.